Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Ling

Showing results (111-120 of 164) with videos related to

Pageof 17
Sort By:
Drug and Alcohol Dependence|April 20, 2006
Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependenceSteven Shoptaw, Alice Huber, James Peck, et al.
Contemporary Clinical Trials|November 20, 2012
Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodologyLarissa J Mooney, Suzanne Nielsen, Andrew Saxon, et al.
Journal of Substance Abuse Treatment|January 19, 2020
Effects of monthly buprenorphine extended-release injections on patient-centered outcomes: A long-term studyWalter Ling, Vijay R Nadipelli, Caitlyn T Solem, et al.
The American Journal on Addictions|February 19, 2010
Conducting clinical research with prescription opioid dependence: defining the populationRoger D Weiss, Jennifer S Potter, Marc L Copersino, et al.
Addiction (Abingdon, England)|November 16, 2011
Double-blind placebo-controlled evaluation of the PROMETA™ protocol for methamphetamine dependenceWalter Ling, Steven Shoptaw, Maureen Hillhouse, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|November 22, 2018
Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trialXuYi Wang, Haifeng Jiang, Min Zhao, et al.
The American Journal of Drug and Alcohol Abuse|July 29, 2009
Urine and plasma pharmacokinetics of lofexidine after oral delivery in opiate-dependent patientsAbeer M Al Ghananeem, Barbara H Herman, Maggie Abbassi, et al.
Journal of Addiction Medicine|July 20, 2011
Health conditions in methamphetamine-dependent adults 3 years after treatmentLarissa J Mooney, Suzette Glasner-Edwards, Patricia Marinelli-Casey, et al.
Substance Abuse and Rehabilitation|June 27, 2019
Measuring recovery in opioid use disorder: clinical utility and psychometric properties of the Treatment Effectiveness AssessmentWalter Ling, Vijay R Nadipelli, Caitlyn T Solem, et al.
Drug and Alcohol Dependence|May 13, 2008
Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependenceSteven Shoptaw, Keith G Heinzerling, Erin Rotheram-Fuller, et al.
Pageof 17

Showing results (111-120 of 164) with videos related to

Sort By:
Pageof 17
Drug and Alcohol Dependence|April 20, 2006
Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependenceSteven Shoptaw, Alice Huber, James Peck, et al.
Contemporary Clinical Trials|November 20, 2012
Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodologyLarissa J Mooney, Suzanne Nielsen, Andrew Saxon, et al.
Journal of Substance Abuse Treatment|January 19, 2020
Effects of monthly buprenorphine extended-release injections on patient-centered outcomes: A long-term studyWalter Ling, Vijay R Nadipelli, Caitlyn T Solem, et al.
The American Journal on Addictions|February 19, 2010
Conducting clinical research with prescription opioid dependence: defining the populationRoger D Weiss, Jennifer S Potter, Marc L Copersino, et al.
Addiction (Abingdon, England)|November 16, 2011
Double-blind placebo-controlled evaluation of the PROMETA™ protocol for methamphetamine dependenceWalter Ling, Steven Shoptaw, Maureen Hillhouse, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|November 22, 2018
Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trialXuYi Wang, Haifeng Jiang, Min Zhao, et al.
The American Journal of Drug and Alcohol Abuse|July 29, 2009
Urine and plasma pharmacokinetics of lofexidine after oral delivery in opiate-dependent patientsAbeer M Al Ghananeem, Barbara H Herman, Maggie Abbassi, et al.
Journal of Addiction Medicine|July 20, 2011
Health conditions in methamphetamine-dependent adults 3 years after treatmentLarissa J Mooney, Suzette Glasner-Edwards, Patricia Marinelli-Casey, et al.
Substance Abuse and Rehabilitation|June 27, 2019
Measuring recovery in opioid use disorder: clinical utility and psychometric properties of the Treatment Effectiveness AssessmentWalter Ling, Vijay R Nadipelli, Caitlyn T Solem, et al.
Drug and Alcohol Dependence|May 13, 2008
Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependenceSteven Shoptaw, Keith G Heinzerling, Erin Rotheram-Fuller, et al.
Pageof 17